Buffer-Loaded Hydrogels for Sustained Tumor pH Neutralization

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing buffering systems for cancer treatment are limited in their ability to regulate the pH of the extracellular cancer environment for extended periods, leading to chemoresistance and metastasis due to ion trapping, and systemic delivery is impractical due to poor bioavailability and side effects.

Innovation Solution

Hydrogel delivery vehicles, such as gellan and PEGDA hydrogels, are used to encapsulate pH buffers for slow and controlled release, regulating pH over multi-day intervals and reducing ion trapping by neutralizing the tumor microenvironment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If bicarbonate buffer is delivered systemically to neutralize tumor acidosis, then pH neutralization is achieved, but bioavailability is poor and side effects occur

Engineering Contradiction:

ImprovepH neutralization efficacyVSAvoidside effects and poor bioavailability

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by transitioning from systemic bicarbonate delivery to localized tumor-targeted buffer therapy. The buffer is delivered specifically to the tumor microenvironment through various administration routes (oral, intravenous, intratumoral), ensuring pH neutralization occurs only where needed (in the acidic tumor extracellular space) rather than systemically, thereby avoiding widespread side effects and improving bioavailability at the target site.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent employs intermediary carriers to deliver bicarbonate buffers to tumors. These intermediaries include liposomes, cellulose-based delivery vehicles, and other carrier systems that transport the buffer selectively to the tumor microenvironment. The intermediary protects the buffer during circulation and facilitates targeted release at the tumor site, overcoming the limitations of direct systemic administration.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If liposomal or cellulose bicarbonate delivery vehicles are used, then short-term pH neutralization is achieved, but the buffering capacity is limited and cannot regulate pH for extended periods

Engineering Contradiction:

ImprovepH neutralizationVSAvoidbuffering duration

Core Design Contradiction:

ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent applies preliminary action by pre-loading high concentrations of bicarbonate buffers into the delivery vehicles before administration. This preliminary loading ensures that sufficient buffering capacity is available to counteract tumor acidosis over extended periods. The buffers are prepared and encapsulated in advance with optimized concentrations to provide sustained neutralization throughout the therapeutic window.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent implements continuity of useful action by designing delivery systems that provide sustained, continuous buffer release rather than single-burst release. The delivery vehicles are engineered to release bicarbonate buffers progressively over time, maintaining pH neutralization continuously in the tumor microenvironment. This continuous action prevents recurrent acidosis and maintains therapeutic efficacy throughout the treatment period.

Inventive Principle:

Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrogel systems effectively neutralize the extracellular pH of cancer cells, increasing the efficacy of weak base chemotherapeutics like doxorubicin and reducing cancer metastasis by maintaining physiological pH levels.

Implementation Method 1

Hydrogels loaded with drug or pH buffer solutions swell and release encapsulants down concentration gradients between the hydrogel and its environment

Methodology Applied

Scientific EffectDiffusion: Diffusion

Implementation Method 2

Hydrogels are polymeric materials characterized by their cross-linked mesh network, hydrophilic nature, high water retention capability

Methodology Applied

Scientific EffectAbsorption: Absorption (physical)

Implementation Method 3

Ionization of the extracellular space renders weak base chemotherapeutics, e.g., doxorubicin, incapable of permeating through phospholipid cell membranes. This form of chemoresistance is termed 'ion trapping'. Ion trapping's effects diminish by the neutralization of the tumor microenvironment using bicarbonate buffer delivery

Methodology Applied

Scientific EffectChemical reaction (neutralization): Chemical Bonding

Data Source

PatentUS20260021127A1pH REGULATING HYDROGELS THAT NEUTRALIZE CANCER CELL ENVIRONMENT ACIDOSIS AND INCREASE CHEMOTHERAPY EFFICACY

Publication Date: 2026.01.22 BROWN UNIVERSITY

AI summary

The invention provides pH regulation systems of buffer-loaded hydrogels that can regulate pH of solutions for long periods of time. These pH-regulating hydrogels may be used in a variety of pH-dependent systems, including water treatment, agricultural soil, and biological applications. Demonstrated is an application in increasing the efficacy of weak base chemotherapeutics used for cancer treatments.